What it Takes to Build a $50B Biotech Moonshot | John Maraganore, Founding CEO of Alnylam Therapeutics
Host Sam Kessel Listen Apple Podcasts Spotify Watch YouTube...
Sam Kessel
Check out the latest posts
Heartbreak to Hope: A Mother’s Mission to Cure Angelman Syndrome, Allyson Berent, CSO, Foundation For Angelman Syndrome Therapeutics (FAST)
A conversation with Dr. Allyson Berent, CSO, Foundation For Angelman Syndrome Therapeutics (FAST)
Decoding the Future: Data, AI, and Biotech | Joe Horsman, Investor at Madrona, on Building at the Intersection of Life & Computer Sciences
A conversation with Joe Horsman, Madrona VC
From science to startup: real talk on biotech founding paths | Hilary Schultz and Dr. William Heath, Persephoni BioPartners
A conversation with Hilary Schultz and Dr. William Heath, CEO and CSO at Persephoni BioPartners
Breakthrough: The stories behind Life-Changing Therapies | Dr. William Pao, former CDO of Pfizer
A conversation with Dr. William Pao, former CDO of Pfizer
Turning Genomic Insights into Breakthrough Therapies | Peter Campbell, CSO of Quotient Therapeutics
A conversation with Dr. Campbell, CSO of Quotient Therapeutics